Targeted Nanozyme Therapy for HER2 Cancer at Salimpour Site.

Dr. Salimpour Site |A new nanozyme-antibody platform selectively targets HER2-positive tumors, disrupting gene expression and reducing metastasis in preclinical models.

AZO Nano

Targeted Nanozyme Therapy for HER2 Cancer

Targeted Nanozyme Therapy for HER2 Cancer

A new nanozyme-antibody platform selectively targets HER2-positive tumors, disrupting gene expression and reducing metastasis in preclinical models.